These Two Marijuana Giants Will Soon Report Earnings, Hear From CEOs At Benzinga Cannabis Conference
Portfolio Pulse from Jelena Martinovic
Curaleaf and MariMed, two major cannabis companies, are set to report their Q3 2024 earnings on November 6. Curaleaf has been expanding internationally, while MariMed is focusing on margin expansion and new assets. Both companies' executives will speak at the Benzinga Cannabis Conference.
October 07, 2024 | 3:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Curaleaf is set to report Q3 earnings on Nov 6, 2024. The company is expanding internationally, with significant growth in the UK and Germany, and has acquired Can4Med in Poland. Shares are slightly down.
Curaleaf's international expansion and recent acquisition in Poland suggest potential revenue growth, which could positively impact the stock. The upcoming earnings report may provide further insights.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
MariMed will announce Q3 earnings on Nov 6, 2024. The company is focusing on margin expansion and has acquired its fifth dispensary in Illinois. Shares are currently down.
MariMed's focus on margin expansion and recent acquisition in Illinois could lead to improved financial performance. The upcoming earnings report will be crucial for assessing progress.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 85